Loading clinical trials...
Loading clinical trials...
To explore the value of MR Fingerprinting-generated quantitative maps combined with ASL renal perfusion imaging in the assessment of renal impairment in chronic kidney disease.
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
The First Affiliated Hospital with Nanjing Medical University
NCT05982496 · Breast Cancer Female, Lobular Breast Carcinoma, and more
NCT07550140 · Cognition, Affect (Mental Function), and more
NCT06755697 · Knee Osteoarthritis, Glucose, and more
NCT07135401 · MRI, MRI Image Enhancement
NCT07028476 · Knee Sprain, Automated Dynamic Laximetry (ADL), and more
The First Affiliated Hospital with Nanjing Medical University
Nanjing, Jiangsu
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions